Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
2,027.30Prev. Close
2,021.80Volume
8,232Total traded value
1.68 CrUpper Circuit
2,426.10Lower Circuit
1,617.50Fundamentals
| Market Cap | ₹33,302Cr |
| ROE | 7.63% |
| P/E Ratio(TTM) | 43.24 |
| EPS(TTM) | 46.75 |
| P/B Ratio | 3.64 |
| Dividend Yield | 0.89% |
| Industry P/E | 35.16 |
| Book Value | 555.41 |
| Debt to Equity | 0.03 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Gland Pharma
Gland Pharma is a leading producer of generic injectable medicines, supplying products to over 60 countries including key markets like the US and Europe. The company's guiding principle is a quality-first approach, prioritizing patient health and leveraging its technical capabilities to meet complex manufacturing requirements efficiently. It operates seven advanced manufacturing facilities across India and has a finished formulation capacity of approximately 1,000 million units.;
| Parent Organisation | Gland Pharma Limited |
| Managing Director | Mr. Srinivasa Sadu |
| NSE Symbol | GLAND |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.73 | ||
| Ajanta Pharma | NA (0.00%) | 34.29 | ||
| Eris Lifesciences | NA (0.00%) | 58.51 | ||
| Sai Life Sciences | NA (0.00%) | 75.42 |